Arce-Huamani, M.A.; Barboza, J.J.; Martínez-Herrera, J.F.; Torres-Roman, J.S.; Maguiña, J.L.
Correction: Arce-Huamani et al. Efficacy and Safety of Apixaban versus Dalteparin as a Treatment for Cancer-Associated Venous Thromboembolism: A Systematic Review and Meta-Analysis. Medicina 2023, 59, 1867. Medicina 2024, 60, 134.
https://doi.org/10.3390/medicina60010134
AMA Style
Arce-Huamani MA, Barboza JJ, Martínez-Herrera JF, Torres-Roman JS, Maguiña JL.
Correction: Arce-Huamani et al. Efficacy and Safety of Apixaban versus Dalteparin as a Treatment for Cancer-Associated Venous Thromboembolism: A Systematic Review and Meta-Analysis. Medicina 2023, 59, 1867. Medicina. 2024; 60(1):134.
https://doi.org/10.3390/medicina60010134
Chicago/Turabian Style
Arce-Huamani, Miguel A., Joshuan J. Barboza, José Fabián Martínez-Herrera, J. Smith Torres-Roman, and Jorge L. Maguiña.
2024. "Correction: Arce-Huamani et al. Efficacy and Safety of Apixaban versus Dalteparin as a Treatment for Cancer-Associated Venous Thromboembolism: A Systematic Review and Meta-Analysis. Medicina 2023, 59, 1867" Medicina 60, no. 1: 134.
https://doi.org/10.3390/medicina60010134
APA Style
Arce-Huamani, M. A., Barboza, J. J., Martínez-Herrera, J. F., Torres-Roman, J. S., & Maguiña, J. L.
(2024). Correction: Arce-Huamani et al. Efficacy and Safety of Apixaban versus Dalteparin as a Treatment for Cancer-Associated Venous Thromboembolism: A Systematic Review and Meta-Analysis. Medicina 2023, 59, 1867. Medicina, 60(1), 134.
https://doi.org/10.3390/medicina60010134
